{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:14:14Z","timestamp":1760037254792,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Pancreatic carcinosarcoma is a rare and aggressive malignancy that can mimic pancreatic adenocarcinomas in presentation but often has different disease biology and different responses to conventional treatment for pancreatic adenocarcinoma. Case reports have documented a 5-year overall survival of approximately 13% only if the disease is caught at an earlier stage and is amenable to multi-modality treatment, including surgery, chemotherapy, and radiation. In the advanced stage, treatments do not often provide benefit, and patients may decline rapidly. There are currently no studies demonstrating survival benefits with chemotherapy in patients with metastatic carcinosarcoma, owing to both the rarity and the often late diagnosis of this aggressive entity. We present a case of a 71-year-old male patient diagnosed with metastatic pancreatic carcinosarcoma who received four lines of palliative-intent treatment: gemcitabine and nab-paclitaxel, modified FOLFIRINOX, GTX, and doxorubicin. With careful selection of chemotherapeutic regimen as well as his ability to tolerate four lines of treatment, this resulted in an unprecedented 26-month survival. We also reviewed the literature on the histopathology, diagnosis, and treatment of this rare entity.<\/jats:p>","DOI":"10.3390\/curroncol32080470","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T15:34:53Z","timestamp":1755531293000},"page":"470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extended Survival with Pancreatic Carcinosarcoma: A Case Report and Literature Review"],"prefix":"10.3390","volume":"32","author":[{"given":"Tian","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON M5G 2M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Browne","sequence":"additional","affiliation":[{"name":"Department of Oncology, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-7727","authenticated-orcid":false,"given":"Morgan","family":"Black","sequence":"additional","affiliation":[{"name":"Department of Oncology, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Marginean","sequence":"additional","affiliation":[{"name":"Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Tsvetkova","sequence":"additional","affiliation":[{"name":"Department of Oncology, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jss.2020.11.033","article-title":"Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database","volume":"259","author":"Alhatem","year":"2021","journal-title":"J. Surg. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11605-017-3607-7","article-title":"A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer","volume":"22","author":"Masuda","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.surg.2020.06.042","article-title":"Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma","volume":"169","author":"Kolbeinsson","year":"2021","journal-title":"Surgery"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12957-021-02478-x","article-title":"Prognosis and survival analysis of patients with pancreatic cancer: Retrospective experience of a single institution","volume":"20","author":"Li","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/MPA.0000000000000904","article-title":"Carcinosarcoma of the Pancreas: Case Report With Comprehensive Literature Review","volume":"46","author":"Ruess","year":"2017","journal-title":"Pancreas"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3390\/curroncol28060442","article-title":"Carcinosarcoma, a Rare Malignant Neoplasm of the Pancreas","volume":"28","author":"Khan","year":"2021","journal-title":"Curr. Oncol."},{"doi-asserted-by":"crossref","unstructured":"Gkountakos, A., Simbolo, M., Bariani, E., Scarpa, A., and Luchini, C. (2022). Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology. Int. J. Mol. Sci., 23.","key":"ref_8","DOI":"10.3390\/ijms23031283"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3892\/ol.2024.14610","article-title":"Sarcomatoid carcinoma of the pancreas (Review)","volume":"28","author":"Ma","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-017-0624-9","article-title":"The epithelial to mesenchymal transition (EMT) and cancer stem cells: Implication for treatment resistance in pancreatic cancer","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/pin.12689","article-title":"Esophageal carcinosarcoma comprised of minimally invasive squamous cell carcinoma and undifferentiated pleomorphic sarcoma: A collision cancer?","volume":"68","author":"Miyauchi","year":"2018","journal-title":"Pathol. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.humpath.2003.02.001","article-title":"Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma","volume":"35","author":"Matsumoto","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1038\/s41467-019-12985-x","article-title":"Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma","volume":"10","author":"Gotoh","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.hpb.2020.01.017","article-title":"Carcinosarcoma of the pancreas: Comprehensive clinicopathological and molecular characterization","volume":"22","author":"Li","year":"2020","journal-title":"HPB"},{"key":"ref_15","first-page":"197","article-title":"Carcinosarcoma of the Pancreas: A Unique Case with Emphasis on Metaplastic Transformation and the Presence of Undifferentiated Pleomorphic High-Grade Sarcoma","volume":"20","author":"Kim","year":"2011","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/his.12975","article-title":"Pancreatic carcinosarcoma with the same KRAS gene mutation in both carcinomatous and sarcomatous components: Molecular evidence for monoclonal origin of the tumour","volume":"69","author":"Bai","year":"2016","journal-title":"Histopathology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.5114\/ada.2024.144486","article-title":"Collision tumours: Our recent experience","volume":"41","author":"Zalewski","year":"2024","journal-title":"Post\u0119py Dermatol. Alergol."},{"key":"ref_18","first-page":"459","article-title":"Mixed tumors and collision tumors: A unifying concept with relevance to diagnosis and classification","volume":"65","author":"Petersson","year":"2015","journal-title":"Path. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3748\/wjg.v21.i4.1357","article-title":"Pancreatic carcinosarcoma: First literature report on computed tomography imaging","volume":"21","author":"Shi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.12998\/wjcc.v9.i13.3102","article-title":"Sarcomatoid carcinoma of the pancreas\u2014Multimodality imaging findings with serial imaging follow-up: A case report and review of literature","volume":"9","author":"Lim","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"397.e7","DOI":"10.1016\/j.crad.2020.01.003","article-title":"Pancreatic sarcomatoid carcinoma: CT, MRI, and 18F-FDG PET\/CT features","volume":"75","author":"Zhao","year":"2020","journal-title":"Clin. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1200\/JCO.2022.40.4_suppl.522","article-title":"Liquid biopsy for diagnosis in patients with suspected pancreatic and biliary tract cancers: PREVAIL ctDNA pilot trial","volume":"40","author":"Mencel","year":"2022","journal-title":"J. Clin. Oncol."},{"doi-asserted-by":"crossref","unstructured":"Grunvald, M.W., Jacobson, R.A., Kuzel, T.M., Pappas, S.G., and Masood, A. (2020). Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer. Int. J. Mol. Sci., 21.","key":"ref_24","DOI":"10.3390\/ijms21207651"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2147\/CMAR.S198429","article-title":"The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: A case series of six patients in one institution","volume":"11","author":"Wang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.26390","article-title":"Sarcomas in TP53 germline mutation carriers: A review of the IARC TP53 database","volume":"118","author":"Ognjanovic","year":"2012","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41698-024-00627-5","article-title":"NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity","volume":"8","author":"Xu","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s13691-025-00770-1","article-title":"Primary carcinosarcoma of the uterine cervix with somatic mutations of the ATM and NF2 genes: A case report","volume":"14","author":"Irie","year":"2025","journal-title":"Int. Cancer Conf. J."},{"doi-asserted-by":"crossref","unstructured":"Azizian, A., R\u00fchlmann, F., Krause, T., Bernhardt, M., Jo, P., K\u00f6nig, A., Klei\u00df, M., Leha, A., Ghadimi, M., and Gaedcke, J. (2020). CA19-9 for detecting recurrence of pancreatic cancer. Sci. Rep., 10.","key":"ref_30","DOI":"10.1038\/s41598-020-57930-x"},{"doi-asserted-by":"crossref","unstructured":"Wlodarczyk, B., Durko, L., Wlodarczyk, P., Talar-Wojnarowska, R., and Malecka-Wojciesko, E. (2023). CA 19-9 but Not IGF-1\/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. J. Clin. Med., 12.","key":"ref_31","DOI":"10.3390\/jcm12124050"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MEG.0000000000002415","article-title":"Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: A systematic review and meta-analysis","volume":"34","author":"Zhao","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pan.2015.10.006","article-title":"Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer","volume":"16","author":"Asaoka","year":"2016","journal-title":"Pancreatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.21873\/anticanres.13455","article-title":"Predictive Factors for Elevated Postoperative Carbohydrate Antigen 19-9 Levels in Patients With Resected Pancreatic Cancer","volume":"39","author":"Takagi","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1477-7819-12-171","article-title":"Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: A pilot study","volume":"12","author":"Dong","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jamcollsurg.2016.02.009","article-title":"Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study","volume":"223","author":"Bergquist","year":"2016","journal-title":"J. Am. Coll. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.3748\/wjg.v20.i35.12682","article-title":"Pancreatic adenocarcinosarcoma of monoclonal origin: A case report","volume":"20","author":"Kim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.14701\/ahbps.22-078","article-title":"Collective review of pancreatic carcinosarcoma, a very rare pancreatic malignancy","volume":"27","author":"Lee","year":"2023","journal-title":"Ann. Hepatobiliary Pancreat. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1440-1746.2012.07112.x","article-title":"Diagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography\/computed tomography for pancreatic malignancy: A meta-analysis using a hierarchical regression model","volume":"27","author":"Wu","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijsu.2017.09.003","article-title":"Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis","volume":"46","author":"Wang","year":"2017","journal-title":"Int. J. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1479416","DOI":"10.1155\/2022\/1479416","article-title":"The Clinical Diagnostic Value of F-FDG PET\/CT Combined with MRI in Pancreatic Cancer","volume":"2022","author":"Liu","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"doi-asserted-by":"crossref","unstructured":"Zhang, J., Jia, G., Zuo, C., Jia, N., and Wang, H. (2017). 18F- FDG PET\/CT helps differentiate autoimmune pancreatitis from pancreatic cancer. BMC Cancer, 17.","key":"ref_43","DOI":"10.1186\/s12885-017-3665-y"},{"doi-asserted-by":"crossref","unstructured":"Dendl, K., Koerber, S.A., Kratochwil, C., Cardinale, J., Finck, R., Dabir, M., Novruzov, E., Watabe, T., Kramer, V., and Choyke, P.L. (2021). FAP and FAPI-PET\/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?. Cancers, 13.","key":"ref_44","DOI":"10.3390\/cancers13194946"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine","volume":"369","author":"Ervin","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21873\/cdp.10303","article-title":"FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel as First Line Treatment in Pancreatic Cancer: A Real-World Comparison","volume":"4","author":"Orlandi","year":"2024","journal-title":"Cancer Diagn. Progn."},{"doi-asserted-by":"crossref","unstructured":"Kciuk, M., Gieleci\u0144ska, A., Mujwar, S., Ko\u0142at, D., Ka\u0142uzi\u0144ska-Ko\u0142at, \u017b., Celik, I., and Kontek, R. (2023). Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. Cells, 12.","key":"ref_47","DOI":"10.3390\/cells12040659"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"119527","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"doi-asserted-by":"crossref","unstructured":"Gurruchaga, S.I., G\u00f3mez-Mateo, M.C., Ortega Izquierdo, M.E., and Mart\u00ednez-Trufero, J. (2024). Beneficial Use of the Combination of Gemcitabine and Dacarbazine in Advanced Soft Tissue Sarcomas: Real-World Data. Cancers, 16.","key":"ref_49","DOI":"10.3390\/cancers16020267"},{"doi-asserted-by":"crossref","unstructured":"Imaoka, H., Ikeda, M., Maehara, K., Umemoto, K., Ozaka, M., Kobayashi, S., Terashima, T., Inoue, H., Sakaguchi, C., and Tsuji, K. (2020). Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: A retrospective multicenter cohort study. BMC Cancer, 20.","key":"ref_50","DOI":"10.1186\/s12885-020-07462-4"},{"key":"ref_51","first-page":"1327","article-title":"Pembrolizumab in MSI-high Pancreatic Sarcomatoid Carcinoma","volume":"8","author":"Mayrhofer","year":"2021","journal-title":"Ann. Hematol. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00435","DOI":"10.14309\/crj.0000000000000435","article-title":"Treatment of Rare and Aggressive Pancreatic Carcinosarcoma","volume":"7","author":"Quinn","year":"2020","journal-title":"ACG Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e262648","DOI":"10.1136\/bcr-2024-262648","article-title":"Pancreatic carcinosarcoma: A rare type of pancreatic neoplasia with long-term survival","volume":"18","author":"Gilani","year":"2025","journal-title":"BMJ Case Rep."},{"key":"ref_54","first-page":"50","article-title":"Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature","volume":"9","author":"Gelos","year":"2008","journal-title":"J. Pancreas"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12032-010-9804-9","article-title":"Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: A case report with a literature review","volume":"29","author":"Zhu","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e5966","DOI":"10.1097\/MD.0000000000005966","article-title":"Pancreatic carcinosarcoma with rare long-term survival: Case report and review of the literature","volume":"96","author":"Jia","year":"2017","journal-title":"Medicine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2324709617740906","DOI":"10.1177\/2324709617740906","article-title":"Primary Carcinosarcoma of the Pancreas With CD10-Positive Sarcoma Component","volume":"5","author":"Salibay","year":"2017","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/08998280.2018.1444302","article-title":"Locally advanced carcinosarcoma of the pancreas","volume":"31","author":"Still","year":"2018","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/cco-21-119","article-title":"Neoadjuvant treatment of pancreatic carcinosarcoma: A case report and review of literature","volume":"11","author":"Lalonde","year":"2022","journal-title":"Chin. Clin. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/8\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:30:22Z","timestamp":1760034622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/8\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["curroncol32080470"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32080470","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}